BMO Capital Upgrades Ionis Pharmaceuticals (IONS) to Outperform; To Benefit form Alnylam Failure
Go back to BMO Capital Upgrades Ionis Pharmaceuticals (IONS) to Outperform; To Benefit form Alnylam Failure| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 288.18 +1.77 (0.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $286.41 | 52 Week High | $109.10 | |||
| Open | $290.89 | 52 Week Low | $31.38 | |||
| Day High | $291.95 | P/E | N/A | |||
| Day Low | $285.26 | EPS | $-1.45 | |||
| Volume | 1,087,832 | |||||
| (NASDAQ: IONS) | Delayed: 75.99 +0.10 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $75.89 | 52 Week High | $62.68 | |||
| Open | $75.89 | 52 Week Low | $19.59 | |||
| Day High | $77.31 | P/E | N/A | |||
| Day Low | $75.77 | EPS | $0.00 | |||
| Volume | 1,405,390 | |||||
